Sanofi Collaborates with Translate Bio to Develop Novel mRNA Vaccine Against COVID-19

 Sanofi Collaborates with Translate Bio to Develop Novel mRNA Vaccine Against COVID-19

Sanofi Collaborates with Translate Bio to Develop Novel mRNA Vaccine Against COVID-19

Shots:

  • Translate Bio will utilize its mRNA platform to discover, design, and manufacture SARS-CoV-2 vaccine candidates while Sanofi will provide its vaccine expertise in advancing the vaccine candidates for further development
  • The collaboration leverages the existing 2018 agreement signed b/w the companies for developing mRNA vaccines for infectious diseases
  • The collaboration marks the Sanofi’s second collaboration for developing vaccine candidates against COVID-19. Initially, the company has collaborated with BARDA to advance vaccine candidates in Feb’2020

Click here ­to­ read full press release/ article | Ref: Sanofi | Image: WFMZ

Tuba Khan

Tuba Khan is an Editor and Digital Marketing expert at PharmaShots. She is curious, creative, and passionate about recent updates and innovation in Lifesciences industry. She covers Pharma, Medical devices, Diagnostics and Digital health segment. Tuba also has an experience of digital and social media marketing and can run the campaign independently. She is also certified as a Digital marketer and social media marketer. She can be contacted on tuba@pharmashots.com

Related post